Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Osterlund

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Cancers|December 23, 2022
Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging ParametersMasoud Karimi, Pia Osterlund, Klara Hammarström, et al.
Clinical Nutrition ESPEN|May 2, 2026
Get a grip! - Baseline Handgrip Strength and Sarcopenia as Predictors of Survival in Patients with Head and Neck Squamous Cell CarcinomaHelena Orell, Anne Pohju, Paula Ravasco, et al.
Oncology Letters|January 8, 2014
<i>Helicobacter pylori</i> and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancerLeena-Maija Soveri, Pia Osterlund, Tarja Ruotsalainen, et al.
Frontiers in Nutrition|December 9, 2022
GLIM in diagnosing malnutrition and predicting outcome in ambulatory patients with head and neck cancerHelena Kristiina Orell, Anne Katariina Pohju, Pia Osterlund, et al.
Journal of Clinical Gastroenterology|October 24, 2012
Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancerReetta Holma, Riitta Korpela, Ulla Sairanen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 4, 2004
Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancerPia Osterlund, Tarja Ruotsalainen, Katri Peuhkuri, et al.
Genes, Chromosomes & Cancer|September 17, 2011
MicroRNA profiling differentiates colorectal cancer according to KRAS statusNeda Mosakhani, Virinder Kaur Sarhadi, Ioana Borze, et al.
The Oncologist|May 8, 2026
Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysisPer Pfeiffer, Chiara Cremolini, Michel Ducreux, et al.
Cancer Treatment Reviews|February 28, 2026
Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature reviewSalvatore Siena, Myriam Chalabi, Rachel Goodwin, et al.
Acta Oncologica (Stockholm, Sweden)|August 14, 2020
Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancerKethe Hermunen, Leena-Maija Soveri, Mogens Karsbøl Boisen, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Cancers|December 23, 2022
Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging ParametersMasoud Karimi, Pia Osterlund, Klara Hammarström, et al.
Clinical Nutrition ESPEN|May 2, 2026
Get a grip! - Baseline Handgrip Strength and Sarcopenia as Predictors of Survival in Patients with Head and Neck Squamous Cell CarcinomaHelena Orell, Anne Pohju, Paula Ravasco, et al.
Oncology Letters|January 8, 2014
<i>Helicobacter pylori</i> and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancerLeena-Maija Soveri, Pia Osterlund, Tarja Ruotsalainen, et al.
Frontiers in Nutrition|December 9, 2022
GLIM in diagnosing malnutrition and predicting outcome in ambulatory patients with head and neck cancerHelena Kristiina Orell, Anne Katariina Pohju, Pia Osterlund, et al.
Journal of Clinical Gastroenterology|October 24, 2012
Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancerReetta Holma, Riitta Korpela, Ulla Sairanen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 4, 2004
Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancerPia Osterlund, Tarja Ruotsalainen, Katri Peuhkuri, et al.
Genes, Chromosomes & Cancer|September 17, 2011
MicroRNA profiling differentiates colorectal cancer according to KRAS statusNeda Mosakhani, Virinder Kaur Sarhadi, Ioana Borze, et al.
The Oncologist|May 8, 2026
Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysisPer Pfeiffer, Chiara Cremolini, Michel Ducreux, et al.
Cancer Treatment Reviews|February 28, 2026
Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature reviewSalvatore Siena, Myriam Chalabi, Rachel Goodwin, et al.
Acta Oncologica (Stockholm, Sweden)|August 14, 2020
Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancerKethe Hermunen, Leena-Maija Soveri, Mogens Karsbøl Boisen, et al.
Pageof 5